Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 16.40
  • Annual Dividend & Yield 0.04 (0.03%)
  • Most Recent Dividend 0.027 on 09/22/25
  • Management Fee 0.35%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 29.72% (-2.34%)
  • Historical Volatility 24.40%
  • IV Percentile 64%
  • IV Rank 23.10%
  • IV High 56.80% on 04/08/25
  • IV Low 21.59% on 07/24/25
  • Expected Move (DTE 8) 3.48 (2.82%)
  • Put/Call Vol Ratio 1.71
  • Today's Volume 105,433
  • Volume Avg (30-Day) 62,292
  • Put/Call OI Ratio 1.51
  • Today's Open Interest 1,052,043
  • Open Int (30-Day) 902,516
  • Expected Range 119.77 to 126.73

Price Performance

See More
Period Period Low Period High Performance
1-Month
106.30 +15.95%
on 11/07/25
123.61 -0.29%
on 12/04/25
+15.21 (+14.08%)
since 11/04/25
3-Month
92.64 +33.04%
on 09/15/25
123.61 -0.29%
on 12/04/25
+29.78 (+31.86%)
since 09/04/25
52-Week
66.66 +84.89%
on 04/09/25
123.61 -0.29%
on 12/04/25
+24.46 (+24.76%)
since 12/04/24

Most Recent Stories

More News
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double

What makes analysts so bullish about these three names from the sector?

MEHCQ : 3.6000 (+0.56%)
GHRS : 15.35 (+6.75%)
TYRA : 22.11 (+1.89%)
DMAC : 8.63 (+1.41%)
XBI : 123.25 (+1.17%)
Biotech Sector May Flip to Market Leader by Year-End

As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.

IBB : 172.11 (-0.07%)
GILD : 122.62 (-1.90%)
XBI : 123.25 (+1.17%)
IWM : 251.82 (+0.88%)
Biogen Stock: Analyst Estimates & Ratings

Biogen has lagged the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on the stock’s future performance.

$SPX : 6,857.12 (+0.11%)
XBI : 123.25 (+1.17%)
BIIB : 181.98 (+0.68%)
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?

Incyte has underperformed relative to its biotech peers over the past year, though Wall Street analysts maintain a cautiously optimistic view on the stock’s outlook.

INCY : 100.46 (-1.02%)
EXEL : 44.37 (+0.82%)
XBI : 123.25 (+1.17%)
How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks?

Vertex Pharmaceuticals has outperformed its biotech peers over the past year, yet Wall Street analysts maintain a reasonably optimistic outlook on its future potential.

VRTX : 457.36 (-1.25%)
REGN : 722.80 (-0.12%)
XBI : 123.25 (+1.17%)
Best Biotech Stocks to Buy in 2025

Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.

VRTX : 457.36 (-1.25%)
AKRO : 54.63 (-0.11%)
REGN : 722.80 (-0.12%)
XBI : 123.25 (+1.17%)
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the broader...

SMMT : 18.81 (+2.40%)
XBI : 123.25 (+1.17%)
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies

The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.

TECH : 63.54 (-0.44%)
VRTX : 457.36 (-1.25%)
MRNA : 25.49 (+1.23%)
REGN : 722.80 (-0.12%)
XBI : 123.25 (+1.17%)
Soleno Therapeutics Stock Rockets 34% Pre-Market After FDA Approves Prader-Willi Syndrome Drug: Retail Sentiment Peaks

The company expects the drug, the first approved therapy to address hyperphagia in PWS patients, to be available in the U.S. starting April 2025.

VTI : 337.09 (+0.16%)
SLNO : 52.68 (+3.86%)
XBI : 123.25 (+1.17%)
Sarepta Therapeutics Stock Has A Nightmarish Week After DMD Patient Death, But Retail And Analysts Aren't Giving Up

Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.

SRPT : 22.82 (+4.49%)
IJH : 66.52 (+0.50%)
VTI : 337.09 (+0.16%)
XBI : 123.25 (+1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 127.14
2nd Resistance Point 125.38
1st Resistance Point 124.31
Last Price 123.25
1st Support Level 121.48
2nd Support Level 119.72
3rd Support Level 118.65

See More

52-Week High 123.61
Last Price 123.25
Fibonacci 61.8% 101.86
Fibonacci 50% 95.14
Fibonacci 38.2% 88.41
52-Week Low 66.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar